MétaCan
Menu
← Back to cohort
Record W4406223817 · doi:10.1002/alz.086601

Novel approach to optimization of Alzheimer’s vaccine configuration for maximal targeting of toxic amyloid‐beta oligomers

2024· article· en· W4406223817 on OpenAlexaff
Johanne Kaplan, Ebrima Gibbs, Scott Napper, Erin Scruten, Juliane Coutts, Neil R. Cashman

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsUniversity of SaskatchewanUniversity of British ColumbiaAmorfix (Canada)
Fundersnot available
KeywordsEpitopeELISPOTAntibodyT cellChemistryB cellAdjuvantMolecular biologyPeptide vaccineImmune systemImmunologyBiochemistryBiology

Abstract

fetched live from OpenAlex

Abstract Background A large body of evidence now indicates that the most pathogenic species of Aß in Alzheimer’s disease (AD) consist of soluble toxic oligomers (AßO) as opposed to insoluble fibrils and monomers. Using our computational platform, we identified 4 different AßO‐restricted conformational B cell epitopes (300, 301, 303, 305) that were tested as vaccines for their ability to induce an antibody response that selectively targets toxic AßO, without inducing potentially detrimental B or T cell responses against plaque or normal Aß. A novel ex vivo approach was then used to select an optimal vaccine configuration amongst the 15 possible combinations of the 4 epitopes to provide maximal binding to a toxic oligomer‐enriched low molecular weight (LMW) fraction of soluble AD brain extracts. Method Mice were vaccinated with four different AßO‐restricted conformational B cell epitopes conjugated to KLH to provide T cell help and formulated with QS‐21 adjuvant. Serum IgG titers against the peptide epitopes were measured by ELISA and T helper cell responses by ELISPOT. The reactivity of serum antibodies with AßO versus monomers was evaluated by SPR, and plaque binding by immunohistochemistry. Result All 4 epitopes elicited robust antibody responses when administered either individually or together as part of a quadrivalent vaccine. ELISPOT analysis showed a T cell response to KLH and not the AßO B cell epitopes. Serum antibodies elicited by the monovalent and quadrivalent vaccines all showed the desired selectivity and reacted with AßO only, not monomers nor plaque. Comparison of the SPR binding responses to the toxic AßO‐enriched LMW fraction of AD brain extract by equivalent amounts of IgG from immune serum of monovalent vaccines vs mixtures of 2, 3 or 4 sera was used to rank vaccine configurations. Interestingly, maximal reactivity was observed with immune IgG against the monovalent vaccine containing epitope 301, the target of PMN310, our clinical‐stage monoclonal antibody. There was no advantage of additional epitopes beyond 301 alone. Conclusion Vaccination with AßO‐restricted conformational B cell epitopes conjugated to KLH produced strong antibody responses with no measurable pro‐inflammatory T cell responses against Aß. Immunization with epitope 301 alone was sufficient to produce maximal reactivity against brain AßO.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.043
GPT teacher head0.313
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicAlzheimer's disease research and treatments→French-language works237,207→